ADAG vs ADTX

Adagene Inc. vs Aditxt, Inc. — Valuation Comparison 2026

ADAG

Biotechnology
Adagene Inc.
Quality
7.2
out of 10
Value Trap
36
LOW
Price
$3.97
Last close
Models
9/13
Active
VS

ADTX

Biotechnology
Aditxt, Inc.
Quality
3.1
out of 10
Value Trap
47
WARN
Price
$0.12
Last close
Models
4/13
Active

Model-by-Model Comparison

ModelType ADAG Fair ValueADAG Upside ADTX Fair ValueADTX Upside
Bayesian DCF Intrinsic $1.39 -65.1% $0.15 -22.7%
First Chicago Scenario $0.81 -78.6% $0.18 -7.6%
ML-RIV Intrinsic $0.34 -91.2%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ADAG vs ADTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ADAG vs ADTX — Which Stock Is More Undervalued?

ADAG scores higher with a 7.2/10 quality rating vs ADTX's 3.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Adagene Inc. (ADAG) and Aditxt, Inc. (ADTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ADAG currently trades at $3.97 with a QOC of 7.2/10, while ADTX trades at $0.12 with a QOC of 3.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).